Clinical Trials on Limbal Stem Cell Deficiency in France

Total 84 results

Hospices Civils de Lyon

Recruiting

Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency (FEMJA)

Total Bilateral Limbal Cell Deficiency

France
University Hospital, Montpellier
Institute for Neuroscience Montpellier

Not yet recruiting

Implementation of a Protocol for the Transdifferentiation of Buccal Mucosal Epithelium Into Corneal Epithelium (TransBuCor)

Limbal Stem Cell Deficiency

France
Centre Hospitalier Universitaire de Saint Etienne
Laboratoire Biologie, Ingénierie et Imagerie de la Greffe de Cornée (BiiGC)

Completed

Collection of Ocular Surface Impressions Cytology of the Living Eye From Patients With Dry Eyes or Limbal Stem Cell Deficiency. (ESSO)

Eye Diseases

France
Centre Hospitalier National d'Ophtalmologie des...
Etablissement Français du Sang

Completed

Cell Therapy in Failure Syndromes in Limbal Stem Cells (TC181)

Limbal Deficiency

France
Nantes University Hospital

Completed

Zoledronic Acid in Combination With Interleukin-2 to Expand Vγ9Vδ2 T Cells After T-replete Haplo-identical Allotransplant (HILDEGAZ)

Hematopoietic Stem Cell Transplantation

France
Assistance Publique - Hôpitaux de Paris

Unknown

Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem Cell Transplant (ALTERGREF)

Hematopoietic Stem Cell Transplant

France
Central Hospital, Nancy, France

Recruiting

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation (REAL-GREFFE)

Allogeneic Hematopoietic Stem Cell Transplantation

France
Central Hospital, Nancy, France

Completed

Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation (AMS-haplo)

Stem Cell Transplantation | Haplo-identical

France
Institute of Cardiometabolism and Nutrition, France

Enrolling by invitation

Developing Derived Induced Pluripotent Stem Cells as a Model to Understand Imprinted Disorders (ID-STEM)

Induced Pluripotent Stem Cells

France
Assistance Publique - Hôpitaux de Paris

Completed

Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation (MENINGREF)

Hematopoietic Stem Cell Transplant | Meningococcal Vaccine

France
Hospices Civils de Lyon
BioMérieux

Completed

Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients (VaccHemInf)

Vaccination | Hematopoietic Stem Cells

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (ELDERGRAF)

Stem Cell Transplant

France
Assistance Publique - Hôpitaux de Paris

Unknown

Non Randomized Comparative Study With Control (Allo-NK-CMV)

Allogeneic Hematopoietic Stem Cell Transplantation

France
Centre Hospitalier Universitaire de Nice

Active, not recruiting

Immunomonitoring After Hematopoietic Stem Cell Transplantation (Allo Monitor)

Hematopoietic Stem Cell Transplantation

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child

Children Treated With High-Dose Chemotherapy (HDC) Followed by Haematopoietic Stem Cell Transplantation (HSCT)

France
University Hospital, Geneva
European Society for Blood and Marrow Transplantation

Recruiting

Polymorphisms and Busulfan Pharmacokinetic Study

Children Who Receive a Stem Cell Transplantation With Busulfan IV

Canada, France, Switzerland
University of California, Irvine

Recruiting

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT)

Allogeneic Hematopoietic Stem Cell Transplantation | Hematologic Malignancies | Allogeneic Stem Cell Transplantation

United States
Central Hospital, Nancy, France

Unknown

Dysbiosis and Immune Reconstitution After Allo-HSCT (PARI-DYS)

Hematopoietic Stem Cell Transplantation

France
Centre Hospitalier Universitaire de la Réunion
Institut Paoli-Calmettes

Not yet recruiting

Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of Life, Determinants of Choices and Financial Repercussions (AlloRé)

Allogeneic Hematopoietic Stem Cell Transplantation

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID Patients (HTLP Necker)

Pediatric Patients | Any Type of Severe Combined Immunodeficiency (SCID) | Partial HLA Incompatible Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

France
Assistance Publique - Hôpitaux de Paris
National Research Agency, France

Unknown

Toward Immune Biomarkers for Tolerance and GvHD in Humans (BioGvHD)

Bone Marrow Transplantation | Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

France
Assistance Publique - Hôpitaux de Paris

Completed

Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell (AGRAH003)

Persistent Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

France
Assistance Publique - Hôpitaux de Paris
Agence de La Biomédecine

Completed

Cyclosporine Dose Adjustment According to Calcineurin Activity After Allogeneic Hematopoietic Stem-cell Transplantation (CALCICLO)

Hematopoietic Stem Cell Transplantation | Graft Versus Host Disease

France
Assistance Publique - Hôpitaux de Paris

Unknown

Inflammatory Response to Paramyxovirus Infection in an Ex-vivo Model of Bronchial Epithelial Cells in Allogeneic HSCT Recipients (ALLOVIRO)

Stem Cell Transplantation

France
Fonds de Dotation HTC Project
Pfizer; Gilead Sciences; Novartis Pharmaceuticals; University Hospital, Clermont-Ferrand and other collaborators

Recruiting

Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support (NSFM)

Hematologic Diseases | Bone Marrow Transplantation | Hematopoietic Stem Cell Transplantation

France
Nantes University Hospital

Completed

Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid Malignancies (TLI-ATG)

Haemato-lymphoid Malignancies or Syndromes in Whom Allogeneic Stem Cell Transplantation is Warranted

France
Hospices Civils de Lyon

Recruiting

Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients (MaRROwVacc)

Transplantation, Hematopoietic Stem Cell

France
University Hospital, Lille

Recruiting

Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases (ASTERIA)

Acute Leukemia | Aplasia | Hematopoietic Stem Cell Transplantation (SCT)

France
Centre Hospitalier Universitaire de Besancon

Recruiting

Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation (MetAlloLip)

Hematologic Diseases | Stem Cell Transplantation

France
University Hospital, Limoges

Recruiting

AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients (NAViRe)

Cytomegalovirus Infections | Hematopoietic Stem Cell Transplantation | Antivirals | Antiviral Drug Resistance

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord (MSC-SLE)

Stem Cell Transplant | Lupus Erythematosus

France
Centre Hospitalier Universitaire, Amiens

Unknown

Analysis of Transcriptomic Profile of Graft-versus-host Disease (GHVD) After Allogeneic Grafting of Hematopoietic Stem Cells

Graft Vs Host Disease | Hematopoietic Stem Cells

France
University Hospital, Grenoble
University Hospital, Clermont-Ferrand; Centre Hospitalier Universitaire de... and other collaborators

Unknown

Impact of a Fourth Hexavalent Vaccine After Hematopoietic Stem Cell Transplantation (EVaxAll)

Allograft | Haemopoietic Stem Cell Transplantation

France
Hospices Civils de Lyon

Recruiting

Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation (PHASAL-GA)

Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy

France
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids (MTX-aGVHD)

Stem Cell Transplant Complications | GVHD, Acute | GVH - Graft Versus Host Reaction | Allogeneic Disease

France
Assistance Publique - Hôpitaux de Paris

Completed

Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT) (REG-Allo)

Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies

France
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells (MSC)

SYSTEMIC SCLERODERMA | ALLOGENEIC MESENCHYMAL STEM CELLS | ADULT

France
Assistance Publique - Hôpitaux de Paris

Completed

Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation (alloforb)

Bronchiolitis Obliterans | Allogeneic Stem Cell Transplantation

France
Millennium Pharmaceuticals, Inc.

Terminated

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Allogeneic Hematopoietic Stem Cell Transplantation

United States, Belgium, Sweden, France, Norway
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Completed

Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell Transplant Recipients (NEOMAIT)

Term and Preterm Neonates (24-41 Weeks Gestational Age) | Hematopoietic Stem Cell Transplant Recipient Children

France
Hospices Civils de Lyon

Completed

Vitamin D Status in Children With Sickle Cell Disease Living in Lyon, France (EVADDREP)

Vitamin D Deficiency | Sickle Cell Disease

France
Pathoquest

Unknown

iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients (IDENTIFY)

Stem Cell Transplantation | Febrile Neutropenia | Acute Leukemia | Infection

France
Intergroupe Francophone du Myelome

Completed

Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies (MOZOBIL)

Multiple Myeloma | Blood Stem Cell Transplant Failure

France
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline

Terminated

Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation (RESPPEDOBS)

Bronchiolitis Obliterans | Respiratory Disease | Stem Cell Transplant Complications

France
Central Hospital, Nancy, France

Completed

Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience (covidallo)

COVID-19 | SARS-CoV2 Infection | Allogeneic Stem Cell Transplantation

France
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Completed

Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis (CANHPARI)

Neutropenia | Hematopoietic Stem Cell Transplantation | Hematological Malignancies | Invasive Fungal Disease | Chronic Disseminated Candidiasis

France
Vifor Pharma

Terminated

Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy (AOC-MM)

Iron-Deficiency Anemia

France, Greece
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma

Malignant Brain Tumor | Brain Stem Glioma,

France
Assistance Publique - Hôpitaux de Paris

Unknown

Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans (ALLOPIV)

Acute Respiratory Infection | Allogeneic Hematopoietic Stem Cell Recipients | Parainfluenza Virus (PIV)

France
University Hospital, Bordeaux
Roche Pharma AG

Completed

Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma (RITALLO)

Lymphoma, Follicular | Stem Cell Transplantation

France

Clinical Trials on Limbal Stem Cell Deficiency in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations